Discovery’s headline earnings are expected to rise by up to 36%, supported by South African and Vitality growth.
You must be a subscriber to access all of this content.
GEMS principal officer Stan Moloabi is suspended during an internal review. Learn more about this significant development.
You must be a subscriber to access all of this content.
Gauteng healthcare bribery allegations involve queue jumping, patient files and medicine collection. Officials face investigation.
You must be a subscriber to access all of this content.
GLP-1 generics could cut obesity drug costs, challenge illegal sales and expand access as more semaglutide products seek approval.
You must be a subscriber to access all of this content.
Research funding has partially recovered with the reopening of NIH grants, but new restrictions underscore the need for domestic investment.
You must be a subscriber to access all of this content.
Cancer sugar shield research from UCT reveals how tumours evade immunity and could support new vaccines, biomarkers and precision therapies.
You must be a subscriber to access all of this content.